We investigated the association between perfusion parameters in pretreatment MR imaging and survival outcome. This retrospective study included 61 consecutive patients (median age, 50 years; range, 27-77 years) diagnosed with TNBC who underwent pretreatment DCE breast MR imaging and definitive surgery. The median follow-up time was 46.1 months. Among pretreatment variables, a higher ve value and higher peak enhancement at pretreatment MR imaging were significantly associated with worse disease-specific survival in patients with TNBC. With further validation, these perfusion parameters have the potential to aid in the pretreatment risk stratification of patients with TNBC and in evidence-based clinical decision support.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords